The Cannabis Industry Council (CIC) has published new guidance aimed at supporting members and industry professionals with setting up businesses in the UK, managing contracts, and addressing payment practices. The guidance responds to multiple requests from CIC members for practical and legal support around business formation, contractual obligations, and payment terms. It is designed to […]
Read More
The Cannabis Industry Council is delighted to announce the shortlist for the Cannabis Industry Awards 2025. These nominees represent the very best of our industry – individuals whose dedication, innovation, and compassion exemplify excellence in the UK cannabis sector. Winners will be announced at the awards dinner on Thursday 6 November 2025 at The Honourable […]
Read More
The General Pharmaceutical Council (GPhC) has published a thematic review focusing on the supply of cannabis-based products for medicinal use (CBPMs) by registered pharmacies in the UK. Key Findings The review provides assurance that most pharmacies met the required standards for the safe procurement, storage, and dispensing of CBPMs. This demonstrates that the majority of […]
Read More
In this month’s episode, Luke speaks to John Shute, CEO and co-founder of PufCreativ. John shares his passion for creative marketing campaigns, which, combined with his commitment to social equity in cannabis, has been the driving force behind PufCreativ. The podcast can be listened to now via Spotify, Amazon, Apple and more.
Read More
The Advisory Council on the Misuse of Drugs (ACMD) is conducting a comprehensive review of the 2018 changes to cannabis medicines regulations in the UK. This review will directly shape how CBPMs are regulated, prescribed, and accessed for years to come. The consultation runs until 17 October 2025, 11:59 PM. This briefing provides guidance to […]
Read More
Nominations are now open for the Cannabis Industry Awards 2025, recognising individuals who have made outstanding contributions to the UK’s cannabis sector. The event is kindly presented by Curaleaf Laboratories and EastCann. The awards, hosted by the Cannabis Industry Council, Drug Science, and the Medical Cannabis Clinicians Society, will celebrate excellence across six categories, Winners will […]
Read More
Curaleaf Laboratories and EastCann present the Cannabis Industry Awards 2025, hosted by the Cannabis Industry Council, Drug Science, and the Medical Cannabis Clinicians Society. Together, we are proud to announce the return of the prestigious event, taking place on Thursday, 6 November 2025, at the historic Honourable Artillery Company, Armoury House, City Road, London EC1Y […]
Read More
The Government has stated that “there are no current plans” for electronic prescribing to be enabled for CBPMs from private clinics. In a response to a written question in Parliament, Health Minister Karin Smyth MP stated: “Cannabis-based products for medicinal use are Schedule 2 controlled drugs under the Misuse of Drugs Regulations 2001. Electronic prescribing […]
Read More
The Care Quality Commission (CQC) has published a report entitled ‘The safer management of controlled drugs: Annual update 2024’. This contains a section on CBPMs. CQC note that prescriptions of unlicensed CBPMs in independent services has increased by 130% between 31 March 2023 and 31 March 2024: 1 April 2022 to 31 March 2023: 150,527 […]
Read More
The Government has recently written to the ACMD about part 2 of their ‘barriers to research’ work, with some notable developments: General: “A new cross-government officials working group will focus on any new issues involving research with controlled drugs while also monitoring the changes following your recommendations.” Recommendation 1: Research using Schedule 1 Controlled Drugs […]
Read More